Kashina Bugayong

Program Lead Ultragenyx Pharmaceutical Inc.

Seminars

Wednesday 15th July 2026
Expanded Access in Latin America: Real‑World Lessons from Rare Disease Programs
9:30 am
  • Navigating regulatory and importation bottlenecks in Latin America, including the impact of government changes and evolving approval pathways (with a focus on Mexico, Argentina, and Brazil)
  • Managing operational and supply‑chain challenges in rare disease Expanded Access Programs while balancing global standards with country‑specific realities
  • Strengthening physician engagement to sustain program momentum and patient access in high‑complexity regions
Kashina Bugayong, Global Program Lead, Expanded Access & IST Programs, Ultragenyx